Brief: Tricida Provides Update On FDA Interactions

Tricida

25/02/2021 23:53

Feb 25 (Reuters) - Tricida Inc  TCDA.O :
    * TRICIDA PROVIDES UPDATE ON FDA INTERACTIONS
    * TRICIDA INC - RECEIVED ADL, FROM OFFICE OF NEW DRUGS OF
FDA IN
RESPONSE TO ITS FORMAL DISPUTE RESOLUTION REQUEST SUBMITTED IN
DECEMBER 2020
    * TRICIDA INC - GIVEN FEEDBACK PROVIDED BY FDA IN ADL,
TRICIDA
INTENDS TO CONTINUE VALOR-CKD TRIAL WITHOUT FURTHER
MODIFICATIONS AT PRESENT TIME
    * TRICIDA - BELIEVES TIMELINE TO MEET REQUIREMENTS FOR
ACCELERATED
APPROVAL SUGGESTED IN ADL MAY NOT RESULT IN MOST RAPID
DEVELOPMENT PATH FOR VEVERIMER

Source text for Eikon:  ID:nGNXbB0bwK 
Further company coverage:  TCDA.O 

 ((Reuters.Briefs@thomsonreuters.com;))